DIRECTOR DEALINGS: Glaxo Executives Acquire Shares
LONDON (Alliance News) - GlaxoSmithKline PLC Tuesday said a group of executives, including Chief Executive Andrew Witty, acquired shares as part of a dividend reinvestment of shares held within an ISA at a price of 1583.14 pence per share Friday.
Details are as follows.
<